Name of this trial: OptimUM-10 What type of cancer is this for? Uveal Melanoma Who is this trial for? Subjects with Primary Non-metastatic Uveal Melanoma What biomarkers are involved? Monosomy 3 What is the National Clinical Trial #? NCT07015190; https://clinicaltrials.gov/study/NCT07015190 Brief summary of this trial: A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in
Phone: (800) 411-7999
